Delivery Order SPE2DB20D3303-SPE2DB26FY2K7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,581.94 to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5ML) on November 4, 2025, with an ultimate completion date of November 5, 2025. This competitively awarded, firm fixed-price delivery order represents a routine pharmaceutical procurement with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,052.93 to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5mL) on June 2, 2025, with completion scheduled for June 3, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award to this major pharmaceutical distributor. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $35,155.89 to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of PREVNAR 20 syringe units (0.5ML). This contract represents a firm fixed price delivery order with no set-aside designation, indicating competitive award through open market solicitation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order is scheduled for...
- The Defense Logistics Agency awarded a delivery order valued at $47,295.80 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 syringes (0.5mL) with a completion date of September 10, 2025. This competitively awarded, firm fixed-price contract represents a single delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office location in the same city....
- The Defense Logistics Agency awarded a delivery order valued at $13,145.43 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 syringes (0.5ml) under a firm fixed-price contract. The award was made on September 26, 2025, with an ultimate completion date of September 29, 2025, and represents a non-competitive delivery order executed without a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5mL) valued at $12,951.33 under a firm fixed-price contract. The award was made on May 1, 2025, with an ultimate completion date of May 2, 2025, and does not utilize a set-aside designation. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,267.54 to AmerisourceBergen Drug Corp for PREVNAR 20 syringe (0.5mL) on October 31, 2025, with an ultimate completion date of November 3, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00 and extends through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $5,281.88 to supply PREVNAR 20 syringes (0.5ML) under a firm fixed price contract. The order was competitively awarded with no set-aside designation and is scheduled for completion by September 11, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $36,998.71 firm fixed price delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in 0.5mL syringes. This non-competitive delivery order, issued on September 12, 2025, with an ultimate completion date of September 15, 2025, represents a routine pharmaceutical procurement fulfilling ongoing federal medical supply requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor within the...
- The Defense Logistics Agency awarded a delivery order valued at $12,901.75 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 vaccine syringes (0.5 mL). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by June 27, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB26FY2K7Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 syringe doses (0.5 mL) with a ceiling value of $1,633.77. The contract was awarded on November 6, 2025, with an ultimate completion date of November 7, 2025, utilizing firm fixed pricing with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfilled this order through its place of performance at the same location. This delivery order was issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. The parent IDC enables the company to supply a comprehensive range of pharmaceutical products and medical supplies, including vaccines, brand-name and generic medications, and specialized medical supplies to support military healthcare programs worldwide. This delivery order for PREVNAR 20, a pneumococcal vaccine, represents a routine fulfillment under this expansive pharmaceutical prime vendor agreement serving the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 11/6/25 |